Temporal Aspects of the Action of ASA404 (Vadimezan; DMXAA)

Por Baguley, Bruce C, Siemann, Dietmar W
Publicado em 2010

Preliminary Evidence That High-Dose Vitamin C has a Vascular Disrupting Action in Mice

Por Baguley, Bruce C., Ding, Qi, Richardson, Emma
Publicado no Front Oncol (2014)

The Role of the Hippo Pathway in Melanocytes and Melanoma

Por Kim, Ji Eun, Finlay, Graeme J., Baguley, Bruce C.
Publicado em 2013

Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell lines

Por Kim, Ji Eun, Leung, Euphemia, Baguley, Bruce C., Finlay, Graeme J.
Publicado em 2013

Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells

Por Leung, Euphemia, Kim, Ji Eun, Rewcastle, Gordon W, Finlay, Graeme J, Baguley, Bruce C
Publicado em 2011

Evidence for the Existence of Triple-Negative Variants in the MCF-7 Breast Cancer Cell Population

Por Leung, Euphemia, Kim, Ji Eun, Askarian-Amiri, Marjan, Finlay, Graeme J., Baguley, Bruce C.
Publicado em 2014

Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer

Por Hansji, Herah, Leung, Euphemia Y., Baguley, Bruce C., Finlay, Graeme J., Askarian-Amiri, Marjan E.
Publicado em 2014

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines

Por Leung, Euphemia Y., Askarian-Amiri, Marjan, Finlay, Graeme J., Rewcastle, Gordon W., Baguley, Bruce C.
Publicado no PLoS One (2015)

Epigenetic regulation in human melanoma: past and future

Por Sarkar, Debina, Leung, Euphemia Y, Baguley, Bruce C, Finlay, Graeme J, Askarian-Amiri, Marjan E
Publicado no Epigenetics (2015)

Signaling Pathways in Melanogenesis

Por D’Mello, Stacey A. N., Finlay, Graeme J., Baguley, Bruce C., Askarian-Amiri, Marjan E.
Publicado no Int J Mol Sci (2016)

Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells

Por Leung, Euphemia, Rewcastle, Gordon W., Joseph, Wayne R., Rosengren, Rhonda J., Larsen, Lesley, Baguley, Bruce C.
Publicado em 2011

Retrotransposon Hypomethylation in Melanoma and Expression of a Placenta-Specific Gene

Por Macaulay, Erin C., Roberts, Hester E., Cheng, Xi, Jeffs, Aaron R., Baguley, Bruce C., Morison, Ian M.
Publicado em 2014

Relationships between Signaling Pathway Usage and Sensitivity to a Pathway Inhibitor: Examination of Trametinib Responses in Cultured Breast Cancer Lines

Por Leung, Euphemia Y., Kim, Ji Eun, Askarian-Amiri, Marjan, Rewcastle, Gordon W., Finlay, Graeme J., Baguley, Bruce C.
Publicado em 2014

MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a “Genetic Switch” Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma

Por Eccles, Michael R., He, Shujie, Ahn, Antonio, Slobbe, Lynn J., Jeffs, Aaron R., Yoon, Han-Seung, Baguley, Bruce C.
Publicado em 2013

Hormone Resistance in Two MCF-7 Breast Cancer Cell Lines is Associated with Reduced mTOR Signaling, Decreased Glycolysis, and Increased Sensitivity to Cytotoxic Drugs

Por Leung, Euphemia Yee, Kim, Ji Eun, Askarian-Amiri, Marjan, Joseph, Wayne R., McKeage, Mark J., Baguley, Bruce C.
Publicado em 2014

Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth

Por Sweetlove, Melanie, Wrightson, Emma, Kolekar, Sharada, Rewcastle, Gordon W., Baguley, Bruce C., Shepherd, Peter R., Jamieson, Stephen M. F.
Publicado no Front Oncol (2015)

Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative

Por Reynisson, Jóhannes, Jaiswal, Jagdish K., Barker, David, D’mello, Stacey A. N., Denny, William A., Baguley, Bruce C., Leung, Euphemia Y.
Publicado no Cancer Cell Int (2016)

ZFAS1: a long noncoding RNA associated with ribosomes in breast cancer cells

Por Hansji, Herah, Leung, Euphemia Y., Baguley, Bruce C., Finlay, Graeme J., Cameron-Smith, David, Figueiredo, Vandre C., Askarian-Amiri, Marjan E.
Publicado no Biol Direct (2016)

Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors

Por Stones, Clare J., Kim, Ji Eun, Joseph, Wayne R., Leung, Euphemia, Marshall, Elaine S., Finlay, Graeme J., Shelling, Andrew N., Baguley, Bruce C.
Publicado em 2013

Variable Expression of GLIPR1 Correlates with Invasive Potential in Melanoma Cells

Por Awasthi, Anshul, Woolley, Adele G., Lecomte, Fabienne J., Hung, Noelyn, Baguley, Bruce C., Wilbanks, Sigurd M., Jeffs, Aaron R., Tyndall, Joel D. A.
Publicado em 2013